INNOVATIVE MEDTECH, INC. (IMTH) Financial Statements (2024 and earlier)
Company Profile
Business Address |
2310 YORK ST BLUE ISLAND, IL 60406 |
State of Incorp. | DE |
Fiscal Year End | June 30 |
Industry (SIC) | 504 - Professional And Commercial Equipment And Supplies (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
9/30/2023 MRQ | 6/30/2023 | 12/31/2022 MRQ | 6/30/2022 | 6/30/2021 | 10/31/2014 | 10/31/2013 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 158 | 88 | 301 | 433 | 1 | ||||
Cash and cash equivalents | 158 | 88 | 301 | 433 | 1 | ||||
Receivables | 225 | 214 | 214 | 179 | |||||
Prepaid expense | 2 | 23 | 2 | ||||||
Other undisclosed current assets | 9 | 63 | |||||||
Total current assets: | 394 | 326 | 515 | 677 | 1 | ||||
Noncurrent Assets | |||||||||
Finance lease, right-of-use asset, after accumulated amortization | 16 | 18 | 21 | ✕ | ✕ | ||||
Operating lease, right-of-use asset | 404 | 499 | 589 | 757 | ✕ | ✕ | |||
Property, plant and equipment | 308 | 320 | 333 | ||||||
Long-term investments and receivables | (27) | ||||||||
Accounts and financing receivable, after allowance for credit loss | (27) | ||||||||
Intangible assets, net (including goodwill) | 3,321 | 3,330 | 3,336 | 3,473 | ✕ | ||||
Goodwill | 178 | 178 | 178 | 3,473 | |||||
Intangible assets, net (excluding goodwill) | 3,143 | 3,152 | 3,158 | ||||||
Other undisclosed noncurrent assets | 7 | 7 | 34 | 336 | |||||
Total noncurrent assets: | 4,056 | 4,175 | 4,285 | 4,567 | |||||
TOTAL ASSETS: | 4,450 | 4,501 | 4,800 | 5,244 | 1 | ||||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities, including: | 1,165 | 3,329 | 1,595 | 776 | 1,616 | 1,385 | |||
Interest and dividends payable | ✕ | ✕ | ✕ | 530 | 313 | 249 | |||
Employee-related liabilities | ✕ | ✕ | ✕ | 30 | 30 | ||||
Accounts payable | 776 | ||||||||
Accrued liabilities | 605 | 544 | 1,500 | 1 | 1 | ||||
Other undisclosed accounts payable and accrued liabilities | 559 | 2,785 | 1,595 | (2,030) | 1,272 | 1,105 | |||
Debt | 802 | 328 | 223 | 715 | 729 | 566 | |||
Derivative instruments and hedges, liabilities | 202 | 198 | 227 | 255 | 359 | 436 | |||
Due to related parties | ✕ | 855 | 780 | 49 | 32 | ||||
Other undisclosed current liabilities | 1,407 | 878 | 1,028 | 1,046 | 280 | 249 | |||
Total current liabilities: | 3,576 | 5,588 | 3,852 | 2,792 | 3,033 | 2,667 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 402 | 151 | 729 | 605 | |||||
Long-term debt, excluding current maturities | 328 | 55 | 181 | 14 | |||||
Finance lease, liability | 74 | 96 | 143 | 590 | ✕ | ✕ | |||
Liabilities, other than long-term debt | 242 | 319 | |||||||
Operating lease, liability | 242 | 319 | 405 | ✕ | ✕ | ||||
Other undisclosed noncurrent liabilities | 1,538 | 1,830 | 1,224 | 1,902 | |||||
Total noncurrent liabilities: | 2,182 | 2,301 | 2,358 | 2,507 | |||||
Total liabilities: | 5,758 | 7,889 | 6,210 | 5,299 | 3,033 | 2,667 | |||
Equity | |||||||||
Equity, attributable to parent | (1,308) | (3,388) | (1,410) | (55) | (3,032) | (2,667) | |||
Preferred stock | 1 | 1 | |||||||
Common stock | 0 | 0 | 0 | 0 | 164 | 164 | |||
Additional paid in capital | 35,314 | 31,564 | 31,564 | 14,861 | 7,054 | 7,054 | |||
Accumulated deficit | (36,622) | (34,952) | (32,974) | (14,916) | (10,250) | (9,885) | |||
Total equity: | (1,308) | (3,388) | (1,410) | (55) | (3,032) | (2,667) | |||
TOTAL LIABILITIES AND EQUITY: | 4,450 | 4,501 | 4,800 | 5,244 | 1 |
Income Statement (P&L) ($ in thousands)
9/30/2023 TTM | 6/30/2023 | 12/31/2022 TTM | 6/30/2022 | 6/30/2021 | 10/31/2014 | 10/31/2013 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 1,725 | 1,455 | 1,298 | 349 | ||||
Gain (loss) on disposition of assets for financial service operations | 25 | 111 | 28 | (223) | ✕ | ✕ | ||
Other income | 173 | 103 | 181 | 132 | ✕ | ✕ | ||
Gross profit: | 1,725 | 1,455 | 1,298 | 349 | ||||
Operating expenses | (5,349) | (21,164) | (19,556) | (1,058) | (336) | (284) | ||
Operating loss: | (3,624) | (19,709) | (18,258) | (709) | (336) | (284) | ||
Nonoperating income (expense) (Investment Income, Nonoperating) | (77) | 51 | ||||||
Interest and debt expense | (155) | (244) | (183) | (1,833) | (156) | (232) | ||
Loss from continuing operations: | (3,779) | (19,954) | (18,441) | (2,542) | (569) | (465) | ||
Loss before gain (loss) on sale of properties: | ✕ | ✕ | (18,957) | (18,441) | (2,542) | (569) | (465) | |
Other undisclosed net income (loss) | 382 | 382 | (723) | 204 | ||||
Net loss: | (3,779) | (19,571) | (18,058) | (3,265) | (365) | (465) | ||
Other undisclosed net income (loss) attributable to parent | 131 | (6) | (102) | |||||
Net loss attributable to parent: | (3,648) | (19,578) | (18,058) | (3,265) | (365) | (567) | ||
Preferred stock dividends and other adjustments | (257) | |||||||
Net loss available to common stockholders, diluted: | (3,648) | (19,578) | (18,058) | (3,522) | (365) | (567) |
Comprehensive Income ($ in thousands)
9/30/2023 TTM | 6/30/2023 | 12/31/2022 TTM | 6/30/2022 | 6/30/2021 | 10/31/2014 | 10/31/2013 | ||
---|---|---|---|---|---|---|---|---|
Net loss: | (3,779) | (19,571) | (18,058) | (3,265) | (365) | (465) | ||
Comprehensive loss, net of tax, attributable to parent: | (3,779) | (19,571) | (18,058) | (3,265) | (365) | (465) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.